Evonik stock trades at EUR 21.13, valued at EUR 9.8 billion

Published on 10/12/2026 at 13:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik stock was EUR 21.13 on October 12, 2026, versus EUR 21.36. Its P/E is 81.67 and dividend yield is 0.05 percent for the latest quote.

Key points in brief

Evonik stock was EUR 21.13 at Lang & Schwarz on October 12, 2026 at 1:51 p.m. CEST.
The price was 1.08 percent below the Xetra close of EUR 21.36 from October 9, 2026.
Market capitalization was EUR 9.8 billion and the P/E ratio was 81.67.
Evonik's next quarterly statement is scheduled for November 3, 2026.

Fotorealistisches Luftbild eines Spezialchemiewerks mit Destillationstürmen bei Sonnenuntergang — Evonik Industries DE000EVNK013 zeigt ein fotorealistisches Luftbild eines großen Spezialchemiewerks bei Abenddämmerung, Illustration mit AI erstellt.

Evonik (DE000EVNK013) was trading at EUR 21.13 at Lang & Schwarz on October 12, 2026 at 1:51 p.m. CEST, while its market capitalization was EUR 9.8 billion. The price was 1.08 percent below the Xetra close of EUR 21.36 from October 9, 2026.

Intraday quote and range

The Lang & Schwarz bid was EUR 21.12 and the ask was EUR 21.14 at the same timestamp. Evonik's 52-week range was EUR 12.49 to EUR 21.64 as of October 12, 2026, placing the current price EUR 0.51 below the upper end of that range.

Valuation sets the frame

The market capitalization stood at EUR 9.8 billion, while the P/E ratio was 81.67 and the dividend yield was 0.05 percent on October 12, 2026. Those figures give the share a different valuation profile from larger chemicals companies, even though the businesses operate in the same broad industry.

Comparison with peers

Evonik: minus 1.08 percent, P/E 81.67, market capitalization EUR 9.8 billion
BASF (Xetra, EUR): minus 0.72 percent, P/E 7.71, market capitalization EUR 44.2 billion
Covestro (Xetra, EUR): unchanged, P/E -23.74, market capitalization EUR 12.5 billion

Analyst target and next report

EQS News reported on October 6, 2026 that Parmantier & Cie. assigned Evonik a Hold rating and a six-month target of EUR 20.50. The target was EUR 0.63 below the Lang & Schwarz price at the time of this article.

Evonik's investor-relations calendar schedules the publication of its third-quarter 2026 statement for November 3, 2026, according to Evonik. That date is the next concrete reporting milestone for the stock.

Price remains below the Xetra close

At EUR 21.13, Evonik was 1.08 percent below the Xetra close of EUR 21.36 from October 9, 2026, while the quote remained inside its EUR 12.49 to EUR 21.64 52-week range. The further course of trading is shown by the continuously updated real-time quote of Evonik stock.